Why the study?
Do elevated levels of hsCRP and BNP predict cardiac events and mortality in patients with dilated cardiomyopathy?
Population
84 consecutive patients with nonischemic dilated cardiomyopathy (DCM)
Comparison
Elevated high-sensitivity C-reactive protein and… vs Normal/low high-sensitivity C-reactive protein…
Design
Cohort
Follow-up
mean 42 months
Authors
Loading...
Should not yet guide risk stratification in dilated cardiomyopathy; hypothesis-generating association requiring prospective validation.
Do elevated levels of hsCRP and BNP predict cardiac events and mortality in patients with dilated cardiomyopathy?
Elevated hsCRP and BNP are strong, independent predictors of cardiac events and mortality in patients with dilated cardiomyopathy, and their combination provides significant prognostic value.
Ishikawa et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: